The treatment of undifferentiated neuroendocrine tumors

Solcia, 2000, Histological typing of endocrine tumours Johnson, 1983, Carcinoids: the association of histologic growth pattern and survival, Cancer, 51, 882, 10.1002/1097-0142(19830301)51:5<882::AID-CNCR2820510522>3.0.CO;2-8 Rindi, 1996, Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior, World J. Surg., 20, 168, 10.1007/s002689900026 Guiguay, 1997, Tumeurs neuro-endocrines pulmonaires, 107 Hainsworth, 1988, Poorly differentiated neuroendocrine carcinoma of unknown primary site, Ann. Intern. Med., 109, 364, 10.7326/0003-4819-109-5-364 Moertel, 1991, Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin, Cancer, 68, 227, 10.1002/1097-0142(19910715)68:2<227::AID-CNCR2820680202>3.0.CO;2-I Zirkin, 1996, Small cell undifferentiated carcinoma of the colon associated with hepatocellular carcinoma in an immunodeficient patient, Hum. Pathol., 27, 992, 10.1016/S0046-8177(96)90232-4 Staren, 1988, Neuroendocrine carcinomas of the colon and rectum: a clinicopathologic evaluation, Surgery, 104, 1080 Wick, 1984, Thymic carcinoid. A histologic, immunohistochemical and ultrastructural study of 12 cases, Cancer, 53, 475, 10.1002/1097-0142(19840201)53:3<475::AID-CNCR2820530318>3.0.CO;2-W Giovannini, 1995, Métastases hépatiques multiples d'une tumeur indifférenciée, Hepato-Gastroenterology, 2, 571 Oberg, 1994, Treatment of neuroendocrine tumors, Cancer Treat. Rev., 20, 331, 10.1016/0305-7372(94)90016-7 Pelley, 1997, Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract, Curr. Opin. Oncol., 9, 68, 10.1097/00001622-199701000-00011 Cavalli, 1978, VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules, Cancer Treat. Rep., 62, 473 Durand, 1987, Interaction of etoposide and cisplatin in an in vitro tumor model, Cancer Treat. Rep., 71, 673 Schabel, 1979, cis-Dichlorodiamineplatinum (II): combination chemotherapy and cross-resistence studies with tumors of mice, Cancer Treat. Rep., 63, 1459 Ihde, 1997, Cancer of the lung — small cell lung cancer, 849 Davis, 1987, Treatment of metastatic carcinoid and Merckel cell tumors with cisplatin and etoposide, Proc. Am. Soc. Clin. Oncol., 6, 73 Morant, 1989, Complete remission of refractory small cell carcinoma of the pancreas with cisplatin and etoposide, Cancer, 64, 2007, 10.1002/1097-0142(19891115)64:10<2007::AID-CNCR2820641006>3.0.CO;2-7 Greco, 1997, Cancer of unknown primary site, 2, 2423 Seitz, 1995, Cancers neuroendocrines anaplasiques avancés: intérêt de l'association VP16-CDDP, Bull. Cancer, 82, 433 Mitry, 1999, Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin, Br. J. Cancer, 81, 1351, 10.1038/sj.bjc.6690325 Hainsworth, 1997, Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide, J. Clin. Oncol., 15, 2385, 10.1200/JCO.1997.15.6.2385 Andreyev, 1995, Phase II study of continuous infusion fluorouracil and interferon alfa 2-b in the palliation of malignant neuroendocrine tumors, J. Clin. Oncol., 13, 1486, 10.1200/JCO.1995.13.6.1486 Greenberg, 1987, Prognostic factors for gastrointestinal and bronchopulmonary carcinoid tumors, Cancer, 60, 2476, 10.1002/1097-0142(19871115)60:10<2476::AID-CNCR2820601022>3.0.CO;2-R McDermott, 1994, Prognostic variables in patients with gastrointestinal carcinoid tumours, Br. J. Surg., 81, 1007, 10.1002/bjs.1800810725 Modlin, 1997, An analysis of 8305 cases of carcinoid tumors, Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2 Baudin, 1998, Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours, Br. J. Cancer, 78, 1102, 10.1038/bjc.1998.635 Janson, 1997, Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center, Ann. Oncol., 8, 685, 10.1023/A:1008215730767